Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2018-10-15
2019-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
NCT00972452
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
NCT05123963
Effectiveness of Aerobic Exercise to Mitigate Hyperglycemia After Fasted Resistance Exercise
NCT05203653
The Effect of an Acute Bout of Exercise on High-sugar Meal Induced Endothelial Dysfunction
NCT02919488
Hyperglycemia and Exercise.
NCT03284216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GLU+EX
Subjects will consume a 75g glucose beverage three times daily for seven days while participating in five structured aerobic exercise sessions throughout the experimental protocol.
GLU+EX
Subjects will complete 45 minutes of recumbent cycling at 60-65% of age-predicted maximal heart rate five times over seven days while ingesting a 75g glucose beverage three times daily.
GLU
Subjects will consume a 75g glucose beverage three times daily for seven days without participating in structured aerobic exercise.
GLU
Subjects will consume a 75g glucose beverage three times daily over a seven-day period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GLU+EX
Subjects will complete 45 minutes of recumbent cycling at 60-65% of age-predicted maximal heart rate five times over seven days while ingesting a 75g glucose beverage three times daily.
GLU
Subjects will consume a 75g glucose beverage three times daily over a seven-day period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Hyperlipidemia,
* Smoking,
* Heart disease,
* Chest pain upon exertion,
* Previous heart surgeries or history of arrhythmias,
* Diabetes,
* Obesity (body mass index ≥30kg/m2),
* Kidney disease,
* Pulmonary disease,
* Autonomic disorders,
* Individuals whom engage in structured exercise (≥30min, ≥2d/wk),
* Current use of medications which influence outcome measures
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Darren P Casey
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Education Building
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201807752
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.